Published • loading... • Updated
RHHBY's 2025 Results Hit by Currency Headwinds, Sales Up 7% at CER
Swiss pharma giant Roche Holding AG's RHHBY 2025 results were affected by currency headwinds.Sales totaled $74.4 billion, which missed the Zacks …
5 Articles
5 Articles
The pharmaceutical company looks back on a successful fiscal year 2025. The outlook forward also promises growth.
·Zürich, Switzerland
Read Full ArticleThe Rhine-based giant Roche reported sales of 61.52 billion Swiss francs last year, a 2% increase year-on-year. Profitability followed a more pronounced trend, according to Roche's own accounting. Core EBIT rose by 5% to 21.83 billion Swiss francs.
Coverage Details
Total News Sources5
Leaning Left1Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium


